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Abstract
Background: Critically ill patients receiving invasive ventilation are at risk of sputum retention. Mechanical
insufflation-exsufflation (MI-E) is a technique used to mobilise sputum and optimise airway clearance. Recently,
interest has increased in the use of mechanical insufflation-exsufflation for invasively ventilated critically ill adults,
but evidence for the feasibility, safety and efficacy of this treatment is sparse.
The aim of this scoping review is to map current and emerging evidence on the feasibility, safety and efficacy of
MI-E for invasively ventilated adult patients with the aim of highlighting knowledge gaps and identifying areas for
future research. Specific research questions aim to identify information informing indications and contraindications
to the use of MI-E in the invasively ventilated adult, MI-E settings used, outcome measures reported within studies,
adverse effects reported and perceived barriers and facilitators to using MI-E reported.
Methods: We will search electronic databases MEDLINE, EMBASE, CINAHL using the OVID platform, PROSPERO, The
Cochrane Library, ISI Web of Science and the International Clinical Trials Registry Platform. Two authors will
independently screen citations, extract data and evaluate risk of bias using the Mixed Methods Appraisal Tool.
Studies included will present original data and describe MI-E in invasively ventilated adult patients from 1990
onwards. Our exclusion criteria are studies in a paediatric population, editorial pieces or letters and animal or bench
studies. Search results will be presented in a PRISMA study flow diagram. Descriptive statistics will be used to
summarise quantitative data. For qualitative data relating to barriers and facilitators, we will use content analysis
and the Theoretical Domains Framework (TDF) as a conceptual framework. Additional tables and relevant figures
will present data addressing our research questions.
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Discussion: Our findings will enable us to map current and emerging evidence on the feasibility, safety and
efficacy of MI-E for invasively ventilated critically ill adult patients. These data will provide description of how the
technique is currently used, support healthcare professionals in their clinical decision making and highlight areas for
future research in this important clinical area.
Systematic review registration: Open Science Framework submitted on 9 July 2020. https://osf.io/mpksq/.
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Background
Critically ill patients under invasive ventilation are at risk
for sputum retention [1]. The relatively dry gases used
during invasive ventilation cause airway mucosa to pro-
duce more mucus volume, potentially of increased
viscosity [1]. Cough is an important defence mechanism
to clear mucus from the upper and lower airways [1].
The presence of an endotracheal tube impairs the ability
to cough as the vocal cords and glottis cannot be closed.
This prevents the generation of high intrathoracic
pressure and subsequent enhancement of cough velocity
[2, 3]. Furthermore, critically ill patients frequently have
an impaired or no cough reflex due to depressed levels
of consciousness, sedation, muscle weakness or muscle
paralysis. Sputum retention, resulting from an inability
to cough effectively, is one cause of extubation failure
which in turn is associated with increased mortality [4].
There are a number of techniques to mobilise sputum
and optimise airway clearance for invasively ventilated
patients. Endotracheal suctioning is the most common
intervention used to remove retained airway secretions
from within the endotracheal tube, trachea and upper
airways [5]. Endotracheal suctioning though is not ef-
fective for clearing secretions from the lower airways [6].
Mechanical insufflation-exsufflation (MI-E) aids spu-
tum clearance from upper and lower airways. This tech-
nique augments inspiratory and expiratory flows to
improve sputum mobilisation, through the application of
rapidly alternating positive and negative pressure, which
approximates a normal cough [7].
MI-E was originally developed to prevent respiratory
complications associated with sputum retention for pa-
tients with neuromuscular disease [8, 9]. Recently inter-
est has increased in the use of MI-E for invasively
ventilated critically ill adults in the intensive care unit
(ICU) [10]. To date, evidence suggests limited and vari-
able adoption of MI-E in this patient group. Our group
has conducted practice surveys of cough augmentation
techniques in ICUs in Canada [11, 12], the United King-
dom (UK) [13] and the Netherlands [14]. Results from
all surveys illustrated that MI-E was predominantly used
for sputum management in non-intubated patients to
prevent intubation or reintubation [11–13]. Across all
three countries, MI-E was not commonly used in
invasively ventilated patients. Both Canadian and UK
surveys cited lack of clinician expertise and knowledge
as perceived barriers to MI-E use in intubated patients.
Evidence for the feasibility, safety and efficacy of MI-E
in invasively ventilated critically ill adults is sparse [15].
To date, little is known about which patients would
benefit most and in which stage of mechanical ventila-
tion, i.e. before or during weaning or following extuba-
tion to prevent reintubation; the most appropriate
technique or MI-E set up regarding pressure, flow and
timing of insufflation and exsufflation; incidence of ad-
verse events; reported outcomes; and the barriers and fa-
cilitators for using MI-E for invasively ventilated adults
in an ICU setting.
The primary aim of this scoping review is to map
current and emerging evidence on how to use MI-E for
invasively ventilated adult patients with the aim of
highlighting knowledge gaps and identifying areas for fu-
ture research.
Methods
Study design
Scoping review following the methods outlined by Ark-
sey and O’Malley and advanced by other authors [16–
18].
Study questions
We will address the following study questions:
1 What primary clinical ICU diagnoses and/or
reasons for mechanical ventilation are an indication
to use/not use MI-E during invasive ventilation?
2 What are the clinical indications (i.e. sputum
removal) and contraindications for commencing
MI-E in invasively ventilated critically ill adults?
3 What MI-E settings are used for invasively venti-
lated critically ill adults? (i.e. interface type, flow,
pressure and time settings)
4 What outcomes are reported in studies of MI-E for
invasively ventilated critically ill adults and how are
these outcomes measured?
5 What adverse events attributed to MI-E use are re-
ported in the evidence base, and how are these de-
fined/described?
Swingwood et al. Systematic Reviews           (2020) 9:287 Page 2 of 5
6 What perceived barriers and facilitators to using
MI-E for invasively ventilated critically ill adults are
described in the evidence base, and how are these
defined?
Identifying relevant studies
The search strategy will be developed in consultation
with a medical information specialist and applied to the
following bibliographic electronic databases: MEDLINE,
EMBASE and CINAHL using the OVID platform. We
will search PROSPERO and The Cochrane Library for
relevant reviews, ISI Web of Science for conference ab-
stracts and the International Clinical Trials Registry Plat-
form (apps.who.int/trialsearch) for unpublished and
ongoing trials. We will screen reference lists of included
articles for additional studies meeting our inclusion cri-
teria listed below.
A modified version of the published search strategy of
the Cochrane systematic review of cough augmentation
techniques will be used [15]. Modification was made to
solely focus on MI-E in an adult population. Addition-
ally, we will not exclude studies based on study design.
The search strategy is provided in Additional file 1. We
will not restrict article selection based on language. In-
clusion and exclusion criteria are shown in Table 1.
Selection of studies
Two review authors (ES and WS) will independently
screen titles and abstracts identified by our search
methods. Full texts of studies considered by either au-
thor as potentially eligible will be obtained and reviewed
to confirm selection against the inclusion/exclusion cri-
teria. Any disagreements throughout the review process
will be resolved by discussion or referred to a third re-
viewer for arbitration (LR/FP). Endnote x9 will be used
to select articles independently.
Data charting process
The research team has developed the data charting form
[17, 19] to collect information pertinent to our research
questions. The data charting tool will be piloted by two
authors (ES and WS) on five articles, with further refine-
ment following discussion as required. Data will include
article study demographics (author, year of publication,
study location and population); study design and aim;
primary clinical ICU diagnoses or reasons for mechan-
ical ventilation of patients that use/do not use MI-E dur-
ing invasive ventilation (RQ1); clinical indications and
contraindications for using MI-E (RQ2); technical or
practical application of MI-E (RQ3); study outcomes and
measures (RQ4); adverse events/side effects (RQ5); and
perceived barriers and facilitators to use of MI-E for in-
vasively ventilated patients (RQ6).
Two reviewers (ES and WS) will independently chart
these data using the data charting form. Data charting
will be managed by two reviewers (WS and ES).
One reviewer will be responsible for contacting key
author when clarification or additional data are needed.
Contact efforts will be limited to a maximum of 3
emails.
Analysis of data
Three steps will be used to collate results [17]. Descrip-
tive statistics will be used to summarise quantitative
data. We will present counts and proportions of studies
reporting each outcome that have been used by re-
searchers. For qualitative data relating to barriers and fa-
cilitators, we will use content analysis and the
Theoretical Domains Framework (TDF) as a conceptual
framework [20, 21]. Finally, we will apply meaning to the
results through the generation of recommendations for
practice and future research based on our analyses.
Assessment of methodological quality of individual
studies
Although the assessment of risk of bias is not essential
for scoping reviews [18], we will use the Mixed Methods
Appraisal Tool (MMAT) [22] to give an overview of the
validity of current evidence. Previous studies have shown
the MMAT to be an easy to use tool with moderate to
perfect inter-rater reliability [22]. Two review authors
(ES/WS) will independently complete quality
Table 1 Inclusion and exclusion criteria for studies
Inclusion Exclusion
Mechanically ventilated adults via tracheostomy or endotracheal tube in a relevant
clinical location (intensive care, weaning centres, respiratory high care/dependency areas)
Children (< 18 years)
Describes use of MI-E Editorial pieces
Letters to the Editor
Any study design
(include randomised controlled trials (RCT), quasi and non-randomised clinical trials,
before and after studies, interrupted time series cohort studies, qualitative designs,
mixed methods, cross-sectional design, case reports/series, and research letters which
present original data)
Bench and animal studies
Published from 1990 onwards
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assessment. We will not exclude studies from the review
due to determined quality. Quality assessment instead
will be used to facilitate description of rigour of included
studies.
Presentation of findings
We will present our search results in a PRISMA study
flow diagram [18] illustrating the total number of articles
generated from the search strategy and following appli-
cation of the inclusion/exclusion criteria, the number
subsequently excluded and ultimately used for review.
A summary table will illustrate study characteristics
from included articles, including population, study coun-
try, study design and methods. Additional tables and
relevant figures will present data addressing our research
questions. Where qualitative data is attained, tables will
be produced to highlight key thematic content within
each TDF domain.
Amendments
The protocol will be closely followed throughout with
regular progress reports as a whole study team. If any
amendments are made to the published study protocol,
these will be reported in the final publication.
Dissemination of findings
We plan to disseminate results from this review in a
peer-reviewed journal.
Discussion
There is growing interest in the role of MI-E for inva-
sively ventilated critically ill adults but to date adoption
and application of this technique is variable [11–13].
The primary aim of this scoping review is to map emer-
ging and current evidence, on MI-E in an ICU setting,
thus adding to previous Cochrane Review findings [15].
Our protocol also aims to apply the TDF framework to
explore the perceived barriers and facilitators for MI-E
use [20, 21]. Barriers and facilitators will be considered
for the feasibility of this technique.
The results of this review will highlight gaps in the
current evidence base to inform future research and will
contribute to the clinical decision making processes of
healthcare professionals who work with MI-E or are
considering use of the technique within their ICU.
Strength and limitations
The protocol for this scoping review is transparent and
in line with the PRISMA scoping review checklist [18]
and the recent scoping review checklist [23]. Strengths
include rigorous and systematic search, inclusion of
studies in all languages, independent selection of studies
and quality assessment using the MMAT [22].
A potential limitation is that we are focusing on a very
specific patient group with an age restriction. This may
restrict the amount of articles to be included.
Conclusion
This scoping review will provide a timely overview of
emerging evidence of MI-E in invasively ventilated critic-
ally ill adults. We hope findings will facilitate clinician
understanding the potential application of this technique
for invasively ventilated critically ill adults and will direct
future research.
Supplementary Information
The online version contains supplementary material available at https://doi.
org/10.1186/s13643-020-01547-8.
Additional file 1:. Search strategy
Abbreviations
MI-E: Mechanical insufflation-exsufflation; ICU: Intensive care unit;
RQ: Research question; TDF: Theoretical Domains Framework; MMAT: Mixed
Methods Appraisal Tool; PRISMA: Preferred Reporting Items for Systematic
Reviews and Meta-Analyses
Acknowledgements
None.
Authors’ contributions
ES and WS proposed and developed the scoping review topic. Ideas were
developed further with academic supervisors LT, FC, LR, WSoR, MS and FP.
The authors read and approved the final manuscript.
Funding
This scoping review is funded by a personal (doctoral) grant from
Netherlands Organisation for Scientific Research, held by WS, and a National
Institute for Health Research Clinical Doctoral Research Fellowship held by
ES. The funders had no role in study design, data collection and analysis,
decision to publish or preparation of the manuscript.
Availability of data and materials
The datasets used and/or analysed during the current study are available
from the corresponding author on reasonable request.
Ethics approval and consent to participate
Not applicable.
Consent for publication
Not applicable.
Competing interests
The authors declare that they have no competing interests.
Author details
1Faculty of Health and Social Care, University of the West of England, Bristol,
UK. 2Adult Therapy Services A804, Bristol Royal Infirmary, University Hospitals
Bristol and Weston NHS Foundation Trust, Upper Maudlin Street, Bristol BS2
8HW, UK. 3Faculty of Health, Center of Expertise Urban Vitality, Amsterdam
University of Applied Sciences, Amsterdam, the Netherlands. 4Department of
Intensive Care Medicine, Amsterdam University Medical Centers, location
‘AMC’, Meibergdreef 9, 1105, AZ, Amsterdam, the Netherlands. 5School of
Health and Society, University of Salford, Manchester, UK. 6Alder Hey
Children’s NHS Foundation Trust, Liverpool, UK. 7Faculty of Health and
Applied Sciences, University of the West of England, Bristol, UK. 8Laboratory
of Experimental Intensive Care and Anesthesiology (L·E·I·C·A), Amsterdam
University Medical Centers, location ‘AMC’, Amsterdam, the Netherlands.
9Mahidol–Oxford Tropical Medicine Research Unit (MORU), Mahidol
Swingwood et al. Systematic Reviews           (2020) 9:287 Page 4 of 5
University, Bangkok, Thailand. 10Nuffield Department of Medicine, University
of Oxford, Oxford, UK. 11Department of Cardiology, Amsterdam University
Medical Centers, location ‘AMC’, Amsterdam, the Netherlands. 12Florence
Nightingale Faculty of Nursing, Midwifery and Palliative Care, King’s College
London, London, UK. 13Lane Fox Respiratory Unit, Guy’s and Thomas’
Foundation NHS Hospital Trust, London, UK.
Received: 15 July 2020 Accepted: 26 November 2020
References
1. Fahy JV, Dickey BF. Airway mucus function and dysfunction. N Engl J Med.
2010;363(23):2233–47.
2. McCool FD. Global physiology and pathophysiology of cough: ACCP
evidence-based clinical practice guidelines. Chest. 2006;129(1, Supplement):
48S–53S.
3. Nakagawa NK, Franchini ML, Driusso P, de Oliveira LR, Saldiva PH, Lorenzi-
Filho G. Mucociliary clearance is impaired in acutely ill patients. Chest. 2005;
128(4):2772–7.
4. Rothaar RC, Epstein SK. Extubation failure: magnitude of the problem,
impact on outcomes, and prevention. Curr Opin Crit Care. 2003;9(1):59–66.
5. Sole ML, Bennett M, Ashworth S. Clinical indicators for endotracheal
suctioning in adult patients receiving mechanical ventilation. Am J Crit Care.
2015;24(4):318–24 quiz 325.
6. Ferreira de Camillis ML, Savi A, Goulart Rosa R, Figueiredo M, Wickert R,
Borges LGA, et al. Effects of mechanical insufflation-exsufflation on airway
mucus clearance among mechanically ventilated ICU subjects. Respir Care.
2018;63(12):1471–7.
7. Chatwin M, Toussaint M, Goncalves MR, Sheers N, Mellies U, Gonzales-
Bermejo J, et al. Airway clearance techniques in neuromuscular disorders: a
state of the art review. Respir Med. 2018;136:98–110.
8. Auger C, Hernando V, Galmiche H. Use of mechanical insufflation-
exsufflation devices for airway clearance in subjects with neuromuscular
disease. Respir Care. 2017;62(2):236–45.
9. Bach JR. Mechanical insufflation-exsufflation. Comparison of peak expiratory
flows with manually assisted and unassisted coughing techniques. Chest.
1993;104(5):1553–62.
10. Toussaint M. The use of mechanical insufflation-exsufflation via artificial
airways. Respir Care. 2011;56(8):1217–9.
11. Rose L, Adhikari NK, Poon J, Leasa D, McKim DA. Cough augmentation
techniques in the critically ill: a Canadian national survey. Respir Care. 2016;
61(10):1360–8.
12. Rose L, McKim D, Leasa D, Nonoyama M, Tandon A, Kaminska M, et al.
Monitoring cough effectiveness and use of airway clearance strategies: a
Canadian and UK survey. Respir Care. 2018;63(12):1506–13.
13. Swingwood E, Tume L, Cramp F. A survey examining the use of mechanical
insufflation-exsufflation on adult intensive care units across the UK. J
Intensive Care Soc. 2019. https://journals.sagepub.com/doi/full/10.1177/1
751143719870121.
14. Stilma W, Van Der Hoeven S, Scholte Op Reimer W, Rose L, Schultz M,
Paulus F. Airway care practices in ICUs in the Netherlands – a national
survey. Eur Respir J. 2019;54(suppl 63):PA4011.
15. Rose L, Adhikari NK, Leasa D, Fergusson DA, McKim D. Cough augmentation
techniques for extubation or weaning critically ill patients from mechanical
ventilation. Cochrane Database Syst Rev. 2017;1:Cd011833.
16. Arksey H, O'Malley L. Scoping studies: towards a methodological framework.
Int J Soc Res Methodol. 2005;8(1):19–32.
17. Levac D, Colquhoun H, O'Brien KK. Scoping studies: advancing the
methodology. Implement Sci. 2010;5:69.
18. Tricco AC, Lillie E, Zarin W, O'Brien KK, Colquhoun H, Levac D, et al. PRISMA
extension for scoping reviews (PRISMA-ScR): checklist and explanation. Ann
Intern Med. 2018;169(7):467–73.
19. Tricco AC, Lillie E, Zarin W, O'Brien K, Colquhoun H, Kastner M, et al. A
scoping review on the conduct and reporting of scoping reviews. BMC Med
Res Methodol. 2016;16:15.
20. Atkins L, Francis J, Islam R, O'Connor D, Patey A, Ivers N, et al. A guide to
using the theoretical domains framework of behaviour change to
investigate implementation problems. Implement Sci. 2017;12(1):77.
21. Cane J, O'Connor D, Michie S. Validation of the theoretical domains
framework for use in behaviour change and implementation research.
Implement Sci. 2012;7:37.
22. Pace R, Pluye P, Bartlett G, Macaulay AC, Salsberg J, Jagosh J, et al.
Testing the reliability and efficiency of the pilot mixed methods
appraisal tool (MMAT) for systematic mixed studies review. Int J Nurs
Stud. 2012;49(1):47–53.
23. Cooper S, Cant R, Kelly M, Levett-Jones T, McKenna L, Seaton P, et al. An
evidence-based checklist for improving scoping review quality. Clin Nurs
Res. 2019:1–24. https://doi.org/10.1177/1054773819846024.
Publisher’s Note
Springer Nature remains neutral with regard to jurisdictional claims in
published maps and institutional affiliations.
Swingwood et al. Systematic Reviews           (2020) 9:287 Page 5 of 5
